Literature DB >> 25829731

Splenic and lymph nodal involvement in sarcoidosis mimicking lymphoma on fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.

Rayamajhi Sampanna Jung1, Bhagwant Rai Mittal1, Nagarjuna Venkata Maturu2, Amanjit Bal3, Anish Bhattacharya1, Dheeraj Gupta2.   

Abstract

Sarcoidosis is a multisystemic disease presenting with well-defined, bilateral, symmetric hilar and right paratracheal lymph node enlargement. Recently, fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (F-18 FDG PET/CT) has been used to stage and detect occult site of active inflammation in sarcoidosis. F-18 FDG PET/CT has become a cornerstone imaging modality in the modern lymphoma management, which can present with generalized lymphadenopathy including mediastinal. We present a case series, which shows how sarcoidosis can be a "great mimic of lymphoma" on F-18 FDG PET/CT and how histopathology is essential in diagnosing sarcoidosis and ruling out lymphoma.

Entities:  

Keywords:  Fluorine-18 fluorodeoxyglucose; lymphadenopathy; lymphoma; positron emission tomography/computed tomography; sarcoidosis

Year:  2015        PMID: 25829731      PMCID: PMC4379672          DOI: 10.4103/0972-3919.152975

Source DB:  PubMed          Journal:  Indian J Nucl Med        ISSN: 0974-0244


INTRODUCTION

Sarcoidosis is a multisystem chronic inflammatory condition of unknown etiology characterized by noncaseous epithelioid cell granulomas. Sarcoidosis can involve any organ but, bilateral well-defined, symmetric hilar and right paratracheal lymph nodes enlargement is the most common finding. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (F-18 FDG PET/CT) is now established as a valuable tool for staging, prognostication, radiotherapy planning and response evaluation in several subtypes of lymphoma. F-18 FDG PET/CT has an accuracy of almost 100% in diagnosing primary splenic involvement during initial staging which can either present as diffusely increased FDG uptake greater than that in the liver and bone marrow or as multiple focal areas of intense FDG accumulation with or without corresponding CT lesions. Liver involvement secondary to the lymphoma presents as patchy foci of FDG uptake originating in the portal areas, with higher standardized uptake values (SUV) than those of the surrounding parenchyma. In most cases of secondary hepatic involvement, the spleen is also infiltrated by lymphoma. In the present study, we present four cases of sarcoidosis with spleen and/or hepatic FDG positivity suggesting lymphomatous involvement in the PET/CT.

CASE REPORTS

Four adults, three females and one male with an age range of 45–58 years are described in the study. Characteristics of these patients are given in Table 1.
Table 1

Demographic and clinical features of all patients

Demographic and clinical features of all patients

Case 1

A 58-year-old male presented with dry cough, generalized weakness, and maculopapular rashes on the extremities for 3 months. General physical and systemic examination did not yield any abnormalities. Complete hemogram and erythrocyte sedimentation rate (ESR) were within normal limits. Serum angiotensinogen converting enzyme (ACE) level was elevated. Tuberculin skin test (TST) was negative. A chest radiograph revealed mediastinal lymphadenopathy. F-18 FDG PET/CT showed FDG avid cervical and mediastinal lymphadenopathy. Maximum standardized uptake values (SUVmax) of the spleen, liver and right lower paratracheal lymph node were 7.6, 4.0 and 4.7 respectively [Figure 1a - maximum-intensity-projection (MIP) image]. Diffusely increased FDG uptake was noted in the normal sized spleen which showed no morphological changes in the CT [Figure 1b - transaxial fused, 1c - transaxial CT]. Based on the clinical and imaging findings on PET/CT a provisional diagnosis of lymphoma was made. Skin biopsy showed noncaseating compact epithelioid cell granulomas in the dermis [Figure 1d - photomicrograph, H and E, ×200] and stain for acid fast bacilli was negative. A diagnosis of sarcoidosis was made, and oral prednisolone (0.7 mg/kg/day) was started and after 1-month of therapy patient showed a significant decrease in the cough frequency.
Figure 1

Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography/ computed tomography (CT) images (a) maximum-intensity-projection showing FDG avid cervical and mediastinal lymph nodes. Transaxial fused and (b) Transaxial CT (c) Increased FDG uptake in the normal sized spleen with no morphological changes in the CT. Photomicrograph (H and E, ×200) of skin biopsy (d) Noncaseating compact epithelioid cell granulomas in the dermis suggesting a diagnosis of sarcoidosis

Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography/ computed tomography (CT) images (a) maximum-intensity-projection showing FDG avid cervical and mediastinal lymph nodes. Transaxial fused and (b) Transaxial CT (c) Increased FDG uptake in the normal sized spleen with no morphological changes in the CT. Photomicrograph (H and E, ×200) of skin biopsy (d) Noncaseating compact epithelioid cell granulomas in the dermis suggesting a diagnosis of sarcoidosis

Case 2

A 46-year-old female presented with dry cough for 1-month, low-grade fever, and anorexia. General physical did not yield any abnormalities, and systemic examination revealed splenomegaly. Complete hemogram and ESR were within normal limits. Serum ACE level was elevated. TST test was negative. A chest radiograph revealed mediastinal lymphadenopathy. F-18 FDG PET/CT showed FDG avid cervical, mediastinal, abdominal and pelvic lymphadenopathy. SUVmax of spleen, liver and left hilar lymph node were 16.1, 3.1 and 17.1 respectively [Figure 2a - MIP image]. Diffusely increased FDG uptake was noted in the enlarged spleen [Figure 2b - transaxial fused, 2c - transaxial CT] suggesting that splenic uptake might be lymphomatous in view of the FDG avid lymphadenopathy. Provisional diagnosis of lymphoma was made. Subsequently the patient underwent endobronchial ultrasound-transbronchial needle aspiration from the paratracheal lymph nodes as well as endobronchial and transbronchial lung biopsies, all of which showed noncaseating compact epithelioid cell granulomas with foreign body giant cells in the peribronchial interstitium [Figure 2d - photomicrograph, H and E, ×200] and stain for acid fast bacilli was negative. A diagnosis of sarcoidosis was made and oral prednisolone was started (0.7 mg/kg/day) and after 2 months the patient symptomatically improved now with no fever, improvement in appetite and decrease in cough frequency.
Figure 2

Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography/ computed tomography (CT) images showing FDG avid cervical, mediastinal, abdominal and pelvic lymphadenopathy on the maximum-intensity-projection image. (a) Transaxial fused (b) and transaxial CT (c) images shows increased FDG uptake in the enlarged spleen. Photomicrograph (H and E, ×200) of the endobronchial ultrasound-transbronchial needle aspiration from the paratracheal lymph nodes (d) show noncaseating compact epithelioid cell granulomas with foreign body giant cells in the peribronchial interstitium

Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography/ computed tomography (CT) images showing FDG avid cervical, mediastinal, abdominal and pelvic lymphadenopathy on the maximum-intensity-projection image. (a) Transaxial fused (b) and transaxial CT (c) images shows increased FDG uptake in the enlarged spleen. Photomicrograph (H and E, ×200) of the endobronchial ultrasound-transbronchial needle aspiration from the paratracheal lymph nodes (d) show noncaseating compact epithelioid cell granulomas with foreign body giant cells in the peribronchial interstitium

Case 3

A 45-year-old female presented with dry cough and shortness of breath for 1-month. Complete hemogram was normal, and ESR was raised. General physical and systemic examination did not yield any abnormalities. TST test was negative. A chest radiograph revealed mediastinal lymphadenopathy and subsequent F-18 FDG PET/CT showed FDG avid cervical, mediastinal and abdominal and pelvic lymphadenopathy. SUVmax of spleen, liver, and subcarinal lymph node were 5.7, 2.5 and 7.1 respectively [Figure 3a - MIP image]. Moderate FDG uptake was noted in the entire spleen [Figure 3b - coronal fused, 3c - coronal CT]. Excision biopsy from the cervical lymph node showed noncaseating compact epithelioid cell granulomas in the lymph node [Figure 3d - photomicrograph, H and E, ×200] and stain for acid fast bacilli was negative. A diagnosis of sarcoidosis was made, and the patient was started with oral prednisolone (0.7 mg/kg/day) and is symptomatically improving after 1-month of therapy.
Figure 3

Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography/ computed tomography (CT) images showing FDG avid cervical, mediastinal and abdominal and pelvic lymphadenopathy on the maximum-intensity-projection image (a) with moderate FDG uptake in the entire spleen (b) coronal fused, (c) coronal CT. Photomicrograph (H and E, ×200) of the excision biopsy from the cervical lymph node shows noncaseating compact epithelioid cell granulomas in the lymph node (d)

Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography/ computed tomography (CT) images showing FDG avid cervical, mediastinal and abdominal and pelvic lymphadenopathy on the maximum-intensity-projection image (a) with moderate FDG uptake in the entire spleen (b) coronal fused, (c) coronal CT. Photomicrograph (H and E, ×200) of the excision biopsy from the cervical lymph node shows noncaseating compact epithelioid cell granulomas in the lymph node (d)

Case 4

A 56-year-old female presented with low-grade on and off fever, dry cough and unintentional significant weight loss for 3 months. Complete hemogram and ESR were within normal limits. Serum ACE level was raised. TST test was negative. F-18 FDG PET/CT showed faintly FDG avid cervical, mediastinal and abdominal lymphadenopathy [Figure 4a - MIP image] and intense FDG uptake was noted in ill-defined hypodense lesions in both the lobes of the liver in the periportal region and spleen. SUVmax spleen, liver, and right hilar lymph nodes were 13.3, 7.5 and 4.2, respectively [Figure 4b - transaxial fused, 4c - transaxial CT]. She underwent endobronchial and transbronchial lung biopsies which showed noncaseating compact epithelioid cell granulomas in the peribronchial interstitium [Figure 4d - photomicrograph, H and E, ×200] and stain for acid fast bacilli was negative. A diagnosis of sarcoidosis was made and oral prednisolone (0.7 mg/kg/day) was started and after 4 months patient has shown improvement in symptomatology with increase in weight and complete resolution of cough and fever.
Figure 4

Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (CT) images showing faintly FDG avid cervical, mediastinal and abdominal lymphadenopathy on maximum-intensity-projection image (a) with intense FDG uptake in ill-defined hypodense lesions in both the lobes of the liver in the periportal region and spleen (b) transaxial fused, (c) transaxial CT. Photomicrograph (H and E, ×200) of the lung biopsy shows noncaseating compact epithelioid cell granulomas in the peribronchial interstitium (d)

Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (CT) images showing faintly FDG avid cervical, mediastinal and abdominal lymphadenopathy on maximum-intensity-projection image (a) with intense FDG uptake in ill-defined hypodense lesions in both the lobes of the liver in the periportal region and spleen (b) transaxial fused, (c) transaxial CT. Photomicrograph (H and E, ×200) of the lung biopsy shows noncaseating compact epithelioid cell granulomas in the peribronchial interstitium (d)

DISCUSSION

The spleen is considered an extra nodal site in NHL and appears to be affected in 20% of patients.[1] Spleen is taken as a nodal organ in Hodgkin's lymphoma and literature shows involvement in 30–40% of cases at presentation.[1] Lymphomatous involvement of the spleen is considered if the uptake of FDG is more than the liver uptake on F-18 FDG PET scan. Secondary lymphomatous liver involvement in lymphoma is more common than primary lymphomatous involvement and is said to manifest as small lesions rather than large masses, along with conglomerates of lymph nodes around the porta hepatis and retroperitoneum.[1] Sarcoidosis is a multisystemic granulomatous disease that can involve any organ. Extrapulmonary sarcoidosis occurs in fewer than 5% of cases.[2] Lymphadenopathy is the most common finding in sarcoidosis. Bilateral hilar lymph node enlargement, alone or in combination with mediastinal lymph node enlargement, occurs in an estimated 95% of patients affected with sarcoidosis.[345] Histopathology shows noncaseating granulomas although its presence is not definitive[6] of sarcoidosis. Sarcoidosis is known to exhibit lymph nodal SUVs ranging from 2.0 to 15.8. Hence, there might be elevations of SUVs into the “malignant” range in patients with sarcoidosis[78910] as seen in our cases. This might be attributed to activated macrophages, and lymphocytes that cause increased F-18 FDG uptake. Reported cases of increased splenic FDG uptake include human immunodeficiency virus infection, malaria, infectious mononucleosis, primary splenic lymphoma, congestive splenomegally and therapy with granulocyte colony stimulating factor.[10] Our cases show how lymph nodes, spleen, and liver can be involved in sarcoidosis in patterns similar to lymphoma.

CONCLUSION

Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in sarcoidosis may show increased FDG uptake in the liver and spleen in a pattern which can be mistaken for lymphomatous involvement in lymphoma. These cases highlight the fact that FDG positivity in the spleen or liver in view of generalized lymphadenopathy does not always represents lymphoma.
  10 in total

1.  FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease.

Authors:  Fabio M Paes; Dimitrios G Kalkanis; Panagiotis A Sideras; Aldo N Serafini
Journal:  Radiographics       Date:  2010-01       Impact factor: 5.333

Review 2.  Clinical significance of diffusely increased splenic uptake on FDG-PET.

Authors:  Yiyan Liu
Journal:  Nucl Med Commun       Date:  2009-10       Impact factor: 1.690

Review 3.  Differential diagnoses of bone marrow granuloma.

Authors:  A Eid; W Carion; J S Nystrom
Journal:  West J Med       Date:  1996-06

4.  The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival.

Authors:  C E Henke; G Henke; L R Elveback; C M Beard; D J Ballard; L T Kurland
Journal:  Am J Epidemiol       Date:  1986-05       Impact factor: 4.897

5.  Mortality of intrathoracic sarcoidosis in referral vs population-based settings: influence of stage, ethnicity, and corticosteroid therapy.

Authors:  Jerome M Reich
Journal:  Chest       Date:  2002-01       Impact factor: 9.410

Review 6.  Pulmonary sarcoidosis.

Authors:  J P Lynch; E A Kazerooni; S E Gay
Journal:  Clin Chest Med       Date:  1997-12       Impact factor: 2.878

Review 7.  FDG PET imaging in sarcoidosis.

Authors:  Dragana Sobic-Saranovic; Vera Artiko; Vladimir Obradovic
Journal:  Semin Nucl Med       Date:  2013-11       Impact factor: 4.446

8.  Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis.

Authors:  Alvin S Teirstein; Josef Machac; Orlandino Almeida; Ping Lu; Maria L Padilla; Michael C Iannuzzi
Journal:  Chest       Date:  2007-10-09       Impact factor: 9.410

Review 9.  Sarcoidosis: clinical presentation, diagnosis, and approach to treatment.

Authors:  Marc A Judson
Journal:  Am J Med Sci       Date:  2008-01       Impact factor: 2.378

10.  Evaluation of mediastinal lymph nodes using F-FDG PET-CT scan and its histopathologic correlation.

Authors:  Arvind Kumar; Roman Dutta; Umashankkar Kannan; Rakesh Kumar; Gopi Chand Khilnani; Siddhartha Datta Gupta
Journal:  Ann Thorac Med       Date:  2011-01       Impact factor: 2.219

  10 in total
  1 in total

1.  Corticosteroid Responsive Sarcoidosis with Multisystemic Involvement Years after Initial Diagnosis: A Lymphoma Mimicker on 18-FDG PET/CT.

Authors:  Turker Acar; Recep Savas; Kenan Kocacelebi; Eyup Sabri Ucan
Journal:  J Clin Imaging Sci       Date:  2015-07-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.